Patent · US Active

Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations

US8138314B2 · kind B2 · utility

10Cited by
1References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 2, 2006
Grant dateMar 20, 2012
Priority date
Expiry dateNov 10, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compounds and methods for the ex vivo or in vivo expansion of NK T cells, CD1d-reactive T cells, and JαQ+ T cells, and the modulation of their activities. These compounds and methods have diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.